NOOTROPIL 200MG/ML ORAL SOLUTION Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

nootropil 200mg/ml oral solution

ucb pharma sa (0000003645) 60 allee de la recherche, brussels, 1070 - piracetam - oral solution - 200mg/ml - piracetam (0007491749) 200mg - piracetam

XYZAL 0.5MG/ML ORAL SOLUTION Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

xyzal 0.5mg/ml oral solution

ucb pharma sa (0000003645) 60 allee de la recherche, brussels, 1070 - levocetirizine dihydrochloride - oral solution - 0.5mg/ml - levocetirizine dihydrochloride (8000001832) 0,5mg - levocetirizine

XYZAL 5MG FILM COATED TABLETS Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

xyzal 5mg film coated tablets

ucb pharma sa (0000003645) 60 allee de la recherche, brussels, 1070 - levocetirizine dihydrochloride - film coated tablets - 5mg - levocetirizine dihydrochloride (8000001832) 5mg - levocetirizine

ZYRTEC 0.1% ORAL SOLUTION Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

zyrtec 0.1% oral solution

ucb pharma sa (0000003645) 60 allee de la recherche, brussels, 1070 - cetirizine dihydrochloride - oral solution - 0.1% - cetirizine dihydrochloride (8000001980) 1mg - cetirizine

ZYRTEC 10MG FILM COATED TABLETS Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

zyrtec 10mg film coated tablets

ucb pharma sa (0000003645) 60 allee de la recherche, brussels, 1070 - cetirizine dihydrochloride - film coated tablets - 10mg - cetirizine dihydrochloride (8000001980) 10mg - cetirizine

ZYRTEC-D 5MG/120MG PROLONGED RELEASE TABLETS Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

zyrtec-d 5mg/120mg prolonged release tablets

ucb pharma sa (0000003645) 60 allee de la recherche, brussels, 1070 - pseudoephedrine hydrochloride; cetirizine dihydrochloride - prolonged release tablets - 5mg/120mg - pseudoephedrine hydrochloride (0000345788) 120mg; cetirizine dihydrochloride (8000001980) 5mg - pseudoephedrine, combinations

Bimzelx Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

bimzelx

ucb pharma s.a.   - bimekizumab - Ψωρίαση - Ανοσοκατασταλτικά - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.

Pemetrexed Baxter Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Αντινεοπλασματικοί παράγοντες - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

MIDAZOLAM ACCORD 5MG/ML ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΕΣΗ Η ΕΓΧΥΣΗ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

midazolam accord 5mg/ml διαλυμα για ενεση η εγχυση

accord healthcare limited, united kingdom - ΥΔΡΟΧΛΩΡΙΚΉ ΜΙΔΑΖΟΛΆΜΗ - ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΕΣΗ Η ΕΓΧΥΣΗ - 5mg/ml - 0059467968 - midazolam hydrochloride - 5.000000 mg - midazolam

MIDAZOLAM ACCORD 1MG/ML ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΕΣΗ Η ΕΓΧΥΣΗ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

midazolam accord 1mg/ml διαλυμα για ενεση η εγχυση

accord healthcare limited, united kingdom - ΥΔΡΟΧΛΩΡΙΚΉ ΜΙΔΑΖΟΛΆΜΗ - ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΕΣΗ Η ΕΓΧΥΣΗ - 1mg/ml - 0059467968 - midazolam hydrochloride - 1.000000 mg - midazolam